These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26208008)

  • 21. Comparison of sensitivity of surrogate markers of drug-induced torsades de pointes in canine hearts.
    Chiba K; Sugiyama A; Takasuna K; Hashimoto K
    Eur J Pharmacol; 2004 Oct; 502(1-2):117-22. PubMed ID: 15464097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Torsades de pointes following clarithromycin treatment.
    Gysel M; Vieweg WV; Hasnain M; Hancox JC; Kunanithy V; Baranchuk A
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1485-93. PubMed ID: 24147515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiac arrest due to torsades de pointes ventricular tachycardia in a patient with Lyme carditis].
    Jensen TB; Dalsgaard D; Johansen JB
    Ugeskr Laeger; 2014 Aug; 176(35):. PubMed ID: 25293707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
    Lengyel C; Várkonyi T; Fazekas T
    Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The perfect storm: Torsades de Pointes in a child with leukemia.
    Bagatell R; Hainstock M; Lowe MC; Barber BJ; Samson RA
    Pediatr Blood Cancer; 2007 Dec; 49(7):996-9. PubMed ID: 16333840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone-induced torsades de pointes: the possible facilitatory role of digoxin.
    Bajaj BP; Baig MW; Perrins EJ
    Int J Cardiol; 1991 Nov; 33(2):335-7. PubMed ID: 1743800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of prolonged QT interval and torsades de pointes in the intoxicated patient.
    Kan AA; de Lange DW; Donker DW; Meulenbelt J
    Neth J Med; 2014 Apr; 72(3):119-26. PubMed ID: 24846924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged QT and cardiac arrest after heart transplantation: inherited or acquired?
    Liu T; Shehata M; Chang D; Patel JK; Kittleson MM; Kobashigawa JA; Chugh SS; Wang X
    J Electrocardiol; 2011; 44(3):350-2. PubMed ID: 21276590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired long QT syndrome: long-term electrocardiographic (Holter) recording of torsades de pointes ending in asystole: II.
    Raviña T; Gutierrez J; Raviña P
    Int J Cardiol; 2007 Mar; 116(2):272-5. PubMed ID: 16859777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced prolongation of the QT interval.
    Roden DM
    N Engl J Med; 2004 Mar; 350(10):1013-22. PubMed ID: 14999113
    [No Abstract]   [Full Text] [Related]  

  • 36. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
    Mok NS; Lo YK; Tsui PT; Lam CW
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifactorial QT interval prolongation.
    Digby G; Machaalany J; Malik P; Methot M; Simpson CS; Redfearn D; Baranchuk A
    Cardiol J; 2010; 17(2):184-8. PubMed ID: 20544619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.